Andere Sprachen Isracann Biosciences Inc.

Aktien

A2PT0E

CA46501D1087

IPOT

Markt geschlossen - Canadian Securities Exchange Andere Börsenplätze 16:41:13 05.04.2023			% 5 Tage	% 1. Jan.
0,015 ^CAD	-.--%		-.--%	-.--%

26.04.	Isracann Biosciences Inc. kündigt Rücktritt von Direktoren an	CI
23.01.	Isracann Biosciences Inc. kündigt Änderungen im Management an	CI

Andere Sprachen

Schalten Sie alle Nachrichten frei: Seien Sie als Erster informiert und reagieren Sie vor den Märkten!

100% kostenlose Registrierung

Isracann Biosciences Inc. Announces Resignation of Directors	26.04.
Isracann Biosciences Inc. Announces Management Changes	23.01.
Isracann Biosciences Inc. Appoints Ajay Singh Kaila as Interim CEO	23.01.23
Isracann Biosciences Inc. Announces Resignation of Phil Floucault as Chief Executive Officer	17.01.23
Isracann Biosciences Inc. Announces Resignation of Phil Floucault as Director	17.01.23
Isracann Biosciences Inc. Announces Resignation of James Thompson as Chief Operations Officer	17.01.23
Isracann Biosciences Inc. Announces the Resignation of Irit Arbel as Director	20.12.22
Isracann Biosciences Inc. Reports Earnings Results for the First Quarter Ended August 31, 2022	08.12.22
Isracann Biosciences Inc. Auditor Raises 'Going Concern' Doubt	30.11.22
Isracann Biosciences Inc. Reports Earnings Results for the Full Year Ended May 31, 2022	30.11.22
Isracann Bioscience Inc. Announces Facilitated Genetics Arrive in Israel	28.09.22
Isracann Bioscience Facilitates Cannabis Genetics Shipment to Israel	14.09.22
Isracann Biosciences Inc. Signs Distribution Agreement with Pure Integrative Pharmacy	01.09.22
Isracann Biosciences Inc. Appoints Mark Rypien to Its Advisory Board	23.08.22
Isracann Biosciences Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended February 28, 2022	27.04.22
Isracann Biosciences Inc. Announces Executive Changes	20.04.22
Isracann Biosciences Inc. Announces Executive Changes	15.04.22
Isracann Biosciences Inc. Appoints George Vrabec to the Position of Director of Natural Health Products	13.04.22
Isracann Biosciences Inc. completed the acquisition of Praesidio Health Inc.	12.04.22
Isracann Biosciences Inc. Reports Earnings Results for the Second Quarter and Six Months Ended November 30, 2021	01.02.22

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen Isracann Biosciences Inc.

Aktien

A2PT0E

CA46501D1087

IPOT

Andere Sprachen

Filter